Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): William Whang Added: 5 months ago
AF Symposium 25 — The retrospective study using data from the admIRE trial (NCT05293639) suggests the occurrence of premature ventricular complexes (PVCs) early after atrial fibrillation (AF) ablation is a marker of increased risk of recurrent atrial arrhythmias.In this interview, Dr William Whang (The Mount Sinai Hospital, New York, US) joins us onsite at AF Symposium 25 to discuss the study… View more
Author(s): Carl Streed Added: 1 year ago
EASD 2023 – Dr Carl G Streed (Boston University School of Medicine, US) joins us to summarise healthcare disparities among the LGBTQ+ population.In this interview, Dr Streed discusses the available evidence and explains the minority stress model. This model suggests that experiences of discrimination and stress contribute to worse health outcomes in the LGBTQ community. This can lead to mental… View more
Author(s): Boris Schmidt Added: 1 year ago
What about FARAPULSE and more specifically theFARAWAVE PFA catheter, leads to a highly predictableworkflow and durable pulmonary vein isolation?Prof Boris Schmidt discusses how the purpose-builtFARAWAVE catheter with an over-the-wire design istranslating to rapid, reproducible and predictableprocedure times with a short operator learningcurve.This video is sponsored by Boston Scientific. View more
Author(s): KR Julian Chun Added: 1 year ago
These videos were sponsored by Boston Scientific. View more
Author(s): Emma Sandgren Added: 2 months ago
EHRA 2025 - Outcomes from model screening for atrial fibrillation (AF) show the combination of a risk prediction model and long-term electrocardiogram (ECG) monitoring is superior to standard of care in detecting new cases of AF in a high-risk population aged 65 years or older. In the risk prediction model arm, the incidence of AF after six months was significantly higher than the incidence in… View more
Author(s): William McIntyre Added: 1 year ago
EHRA 24 - Investigator, Dr William McIntyre (Population Health Research Institute, CA) joins us to discuss the findings from a substudy of ARTESiA (NCT01938248).ARTESiA was a randomized, parallel assignment clinical trial which aimed to assess if apixaban could reduce the risk of ischemic stroke and systemic embolism in patients with subclinical atrial fibrillation (AF) and additional risk… View more